Prediction Case File
YouTubeEvaluation Complete

Friends! In this video, I'm going to do an analysis Ferrari stock or RACE stock

1 extracted signal · 1 resolved · 0 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
15 Oct 2025, 22:18 UTC
Recorded by Tahlil Plus
18 May 2026, 20:23 UTC
Video preview for Friends! In this video, I'm going to do an analysis Ferrari stock or RACE stock
Source overview

AI-generated source summary

The analysis reviews Ferrari's business model, highlighting scarcity, pricing power, and recession resistance. It notes Ferrari's limited production of approximately 330,000 cars, with over 90% still in existence. The company's 2030 guidance included revenue targets of 9 billion euros, an adjusted EBITDA margin of at least 40%, adjusted operating profit margin of at least 30%, and adjusted diluted EPS of 11.50 euros. With those metrics model's fair value price of Ferrari's stock in 286.92 USD. Given the information provided, a calculated failure point for the analysis would be anything above $416.76.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Evaluation Complete
Signals
1
Extracted from this source
Open
0
Still being tracked
Successful
0
Resolved successfully
Failed
1
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
0%
1 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    1 eligible signal linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.6
Tracked signals
324
Historical success
34.4%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail